LEADER 01063nlm0 22003491i 450 
001 990009678720403321
005 20130207164630.0
010   $a978-1-4160-9979-6
035   $a000967872
035   $aFED01000967872
035   $a(Aleph)000967872FED01
035   $a000967872
100   $a20130207d2012----km-y0itaa50------ba
101 0 $aeng
102   $aUS
135   $adrnn-008mamaa
200 1 $aClinical veterinary advisor$bRisorsa elettronica$ethe horse$fEditor in chief David A. Wilson
210   $aSt. Louis, Mo$cSaunders Elsevier$dc2012
230   $aDocumento elettronico
300   $aSection IV: Drug formulary
336   $aTesto
337   $aFormato html, pdf
610 0 $aCavalli$aMalattie
676   $a636.108 96
702  1$aWilson,$bDavid A.
801  0$aIT$bUNINA$gREICAT$2UNIMARC
856 4 $zFull text per gli utenti Federico II$uhttp://www.sciencedirect.com/science/book/9781416099796
901   $aEB
912   $a990009678720403321
959   $aFMVBC
996   $aClinical veterinary advisor$9839535
997   $aUNINA